Anmol Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 10-07-2024
- Paid Up Capital ₹ 6.66 Cr
as on 10-07-2024
- Company Age 38 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2019)
- Ebitda
- Net Worth -0.09%
(FY 2019)
- Total Assets -0.05%
(FY 2019)
About Anmol Drugs And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 6.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shatrughan Tiwari, Balam Rawat, and Rajat Jain serve as directors at the Company.
- CIN/LLPIN
L24239DL1986PLC025187
- Company No.
025187
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Aug 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anmol Drugs And Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shatrughan Tiwari  | Director | 01-Jan-2003 | Current |
| Balam Rawat | Director | 13-Oct-2006 | Current |
| Rajat Jain | Director | 21-Aug-1986 | Current |
Financial Performance of Anmol Drugs And Pharmaceuticals.
Anmol Drugs And Pharmaceuticals Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Anmol Drugs And Pharmaceuticals?
In 2019, Anmol Drugs And Pharmaceuticals had a promoter holding of 8.92% and a public holding of 91.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anmol Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Anmol Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anmol Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anmol Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
